Skip to main content


Figure 2 | Journal of Pharmaceutical Policy and Practice

Figure 2

From: Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in Japan

Figure 2

Recommendation processs flowchart. Antimicrobial use: used Glycopeptides or Carbapenems used 3,4-Generation Cephalosporins or Quinolones for 14 days or more Pathogenic microorganisms: Positive blood cultures, Methicillin-resistant Staphylococcus aureus Extended spectrum beta-lactamase-producing organisms, Acinetobacter baumannii Pseudomonas aeruginosa resistant to at least one among Carbapenems, Quinolones or Aminoglycosides.

Back to article page